Feb 7 (Reuters) - Perrigo Company Plc PRGO.N
* Has filed an abbreviated new drug application with U.S. Food and Drug Administration for Clindamycin
* Notified Valeant Pharmaceuticals (NYSE:VRX) North America, Dow Pharmaceutical Sciences of its ANDA filing
* On February 3, 2017, Valeant filed suit in United States District Court for district of New Jersey alleging patent infringement Source text for Eikon: ID:nPnbZSbyka Further company coverage: PRGO.N